• 1
    Clarke AE, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al, and the Tri-Nation Study Group. The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) 2004; 43: 101624.
  • 2
    Yelin E. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl 2003; 68: 811.
  • 3
    Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40: 3747.
  • 4
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
  • 5
    Brunner HI, Barron AC, Graham TB, Passo MH, Johnson AL, Lenihan J, et al. Effects of treatment on costs & health-related quality of life (HRQL) of children with polyarticular course juvenile rheumatoid arthritis (JRA) [abstract]. Arthritis Rheum 2004; 50 Suppl 9: S686.
  • 6
    Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004; 51: 45864.
  • 7
    Landgraf J, Abetz L, Ware J. The CHQ user's manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
  • 8
    Petty RE, Cassidy JT. Systemic lupus erythematosus. In: CassidyJT, PettyRE, editors. Pediatric rheumatology. Philadelphia: W.B. Saunders Company; 2001. p. 396449.
  • 9
    Bishnoi A, Barron AC, Graham TB, Passo MH, Houk LJ, Mongey AB, et al. Long-term outcomes of childhood-onset systemic lupus erythematosus (cSLE) [abstract]. Arthritis Rheum 2004; 50 Suppl 9: S533.
  • 10
    US Census Bureau. United States Census 2000. URL:
  • 11
    Mok CC, Lee KW, Ho CT, Lau CS, Wong RW. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000; 39: 399406.
  • 12
    Minden K, Niewerth M, Listing J, Biedermann T, Schontube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 83642.
  • 13
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 3902.
  • 14
    Allaire SH, DeNardo BS, Szer IS, Meenan RF, Schaller JG. The economic impacts of juvenile rheumatoid arthritis. J Rheumatol 1992; 19: 9525.
  • 15
    Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 86672.
  • 16
    Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome: a cohort study. Lupus 2000; 9: 6016.
  • 17
    Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 52130.
  • 18
    Nichol MB, Shi S, Knight TK, Wallace DJ, Weisman MH. Eligibility, utilization, and costs in a California Medicaid lupus population. Arthritis Rheum 2004; 51: 9961003.
  • 19
    Clarke A. Economic impact of lupus. Am J Manag Care 2001; 7 Suppl: S496501.
  • 20
    Brunner H, Gladmann DD, Ibanez D, Urowitz MB, Silverman E. Difference in disease features between childhood-onset and adult systemic lupus erythematosus (SLE) [abstract]. Arthritis Rheum 2003; 48 Suppl 9: S506.